«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

24卷

期数:

2018年05期

页码:

385-389

栏目:

基础医学

出版日期:

2018-09-20

文章信息/Info

Title:

The effect of Tregs-infusion under different miR-146a expression on the immune rejection of cardiac allograft in mice

作者:

于 洋¹; 2; 曹际森¹; 3; 王多伟¹; 戚 峰¹

1.天津医科大学总医院普通外科，天津 300052；2.天津港口医院外科，天津 300456；3.天津市第三中心医院肝胆外科, 天津 300170

Author(s):

YU Yang¹; 2; CAO Ji-sen¹; 3; WANG Duo-wei¹; QI Feng¹

1. Department of General Surgery, General Hospital, Tianjin Medical University, Tianjin 300052，China; 2. Department of Surgery, Tianjin Harbor Hospital, Tianjin 300456， China; 3. Department of Hepatobiliary Surgery, Tianjin Third Central Hospital, Tianjin 300170，China

关键词:

miR-146a; 调节T细胞; 心脏移植; T细胞亚群; 急性排斥反应

Keywords:

miR-146a; regulatory T cells; cardiac allograft; T cell subset;  acute rejection

分类号:

R617

DOI:

-

文献标志码:

A

摘要:

目的：本研究探讨调控miR-146a Treg细胞体内回输对小鼠心脏移植免疫排斥反应的影响。方法：流式分选Treg细胞并进行体外扩增。转染试剂分别上调和下调Treg miR-146a表达。建立小鼠心脏移植模型，设立对照组，空白Treg组，miR-146a上调组，miR-146a下调组。移植后回输Treg，观察生存曲线，病理分级，测定受体脾T细胞亚群，RT-PCR检测供心IFN-γ、IL-4、IL-17表达。结果：细胞扩增10倍后miR-146a表达无明显变化,并能有效调控miR-146a表达。回输后空白Treg组（中位生存期11 d）及上调组（中位生存期13 d）生存时间延长，病理分级降低（P<0.05）；上调组更为明显（P<0.05）；下调组（中位生存期7 d）生存时间缩短，病理分级升高（P<0.05），Th1细胞数量（28.6%±2.7%）及供心IFN-γ表达（1.12±0.11）升高（P<0.05）。结论：体外能有效地分选和扩增Treg细胞，并保证miR-146a的表达。回输Treg明显抑制小鼠心脏移植急性排斥反应，上调组抑制功能增强，下调组抑制功能减弱。

Abstract:

Objective: To investigate the effect of regulated Tregs-infusion on cardiac allograft rejection in mice. Methods: Tregs in the spleen of mice in vitro by flow cytometry were separated and proliferated. The cardiac allograft mice model were built and four groups were established： NS control group, empty group, miR-146a-up-regulated group and miR-146a-down-regulated group. We regulated the expression of miR-146a in Tregs, and transfused the Tregs to the cardiac allograft mice model. The survival curve, pathological grade and the T cell subsets in the recipient spleens in different groups were compared. We also detected the expression of IFN-γ, IL-4, IL-17 in donor heart. Results: The proliferation reagent effectively proliferated 10 times the number of Tregs, and there was no significant difference between the expressions of miR-146a before and after the proliferation (P>0.05). Survival time of mice in control group (median survival time: 11 days) and miR-146a-up-regulated group(median survival time: 13 days) was longer than that of miR-146a-down-regulated group(median survival time: 7 days), and the pathological grade was lower (P<0.05); survival time of mice in miR-146a-down-regulated group was shorter than control group and miR-146a-up-regulated group, and the pathological grade was higher (P<0.05). The number of Th1 （28.6%±2.7%） and the expression of IFN-γ（1.12±0.11） in donor heart in miR-146a-down-regulated group were higher (P<0.05). Conclusion: Tregs can be successfully separated and proliferated without affecting the expression level of miR-146a in vitro. Infusion of Tregs can significantly suppress the acute rejection of cardiac allograft in mice, while the suppression function in up-regulated group is stronger than that of down-regulation group.

参考文献/References:

[1] Xu L，Xu W，Wen Z K， et al. In situ prior proliferation of CD4(+) CCR6(+) regulatory T cells facilitated by TGF-beta secreting DCs is crucial for their enrichment and suppression in tumor immunity[J].PLoS One，2011，6（5）:e20282
[2] Liu Z，Wang D，Hu Y L， et al. MicroRNA-146a negatively regulates PTGS2 expression induced by Helicobacter pylori in human gastric epithelial cells[J]. J Gastroenterol，2013，48（1）:86
[3] Fujino M， Zhu P， Cai S， et al. MicroRNAs Involved in Acute Rejection and Tolerance in Murine Cardiac Allografts[J]. Exp Clin Transplant， 2016，14（4）:424
[4] Brunstein C G，Miller J S，Cao Q， et al. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics[J]. Blood，2011，117（3）:1061
[5] 倪一鸣， 冯强， 梁宏立. 小鼠异位心脏移植模型的建立[J]. 中华器官移植杂志，2002（6）:20
[6] Abbott C P， Lindsey E S， Creech O J， et al. A techniqueforhearttransplantationin therat[J]. Arch Surg， 1964，89:645
[7] Ono K，Lindsey E S. Improved technique of heart transplantation in rats[J]. J Thorac Cardiovasc Surg，1969，57（2）:225
[8] Laurence A，Tato C M，Davidson T S， et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell Generation[J]. Immunity，2007，26（3）:371
[9] Miossec P，Korn T，Kuchroo V K. Interleukin-17 and type 17 helper T cells[J]. N Engl J Med，2009，361（9）:888
[10] Tang Y，Luo X，Cui H， et al. MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins[J]. Arthritis Rheum，2009， 60（4）:1065
[11] Yan C，Zhang B B，Hua H， et al. The dynamics of Treg/Th17 and the imbalance of Treg/Th17 in clonorchis sinensis-Infected mice[J].PLoS One，2015，10（11）:e0143217
[12] Fujisawa Y，Nabekura T，Kawachi Y， et al. Enforced ROR（gamma）t expression in haematopoietic stem cells increases regulatory T cell number， which reduces immunoreactivity and attenuates hypersensitivity in vivo[J]. Asian Pacific J Allergy Immunol，2011，29（1）:86
[13] Choi J，Ritchey J，Prior J L， et al. In vivo administration of hypomethylating agents mitigate graft-versus-host disease without sacrificing graft-versus-leukemia[J]. Blood，2010，116（1）:129
[14] Trzonkowski P，Bieniaszewska M，Juscinska J， et al. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127-T regulatory cells[J]. Clin Immunol，2009，133（1）:22
[15] Yuan J，Bagley J，Iacomini J. Hyperlipidemia promotes Anti-Donor Th17 responses that accelerate allograft rejection[J]. Am J Transplant，2015，15（9）:2336

相似文献/References:

备注/Memo

备注/Memo:

基金项目 国家自然科学基金资助项目（8157020853） 作者简介 于洋（1983-），男，主治医师，硕士在读，研究方向：普通外科；通信作者：戚峰，E-mail:qf@medmail.com.cn。

常用功能

更新日期/Last Update: 2018-09-30